Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Stress Shown to Cause Shift in Gene Products

By Biotechdaily staff writers
Posted on 20 May 2002
Stress can cause a shift in gene products (mRNAs) by altered splicing, the normal cut and paste mechanism that modifies mRNA, resulting in different proteins, according to a mouse study conducted by researchers at The Hebrew University of Jerusalem (Israel) and Ben-Gurion University (Be'er Sheva, Israel). More...
The finding was reported in the January 18, 2002, issue of Science.

The study revealed that stress causes changes in the splicing of many gene products, particularly in neurons, which has the result of modifying neuronal proteins. In particular, the ACHE gene, whose protein acetylcholinesterase helps control signaling across synapses, produces a normally rare mRNA following trauma. This mRNA produces an unusual variant of the acetylcholinesterase protein that cannot be integrated into synapses to assist transmission of nerve impulses.

The researchers measured the electrical activity in the brain of mice weeks after the mice were exposed to stress. They found much greater activity in the brains of stressed mice than in nonstressed mice. The researchers note that patients who receive drugs that affect their nervous system may eventually benefit from the recognition that stress renders them more sensitive to these drugs. The new findings suggest that altered mRNAs could be targets for a new class of drugs.

"Our study shows that stress initiates a series of events that includes changes in mRNA splicing and a consequent change of a key protein in neurons that results in an oversensitive electrical response,” said Prof. Hermona Soreq, who led the research team.




Related Links:
Hebrew University
Ben-Gurion Univ.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Automatic CLIA Analyzer
Shine i6000
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.